Femtech World reveals Research Project of the Year shortlist

Three innovative research projects have been shortlisted for a Femtech World Award.

The awards, delivered in partnership with headline sponsor Planned Parenthood, celebrates the brightest lights in women’s health innovation.

The event celebrates some of the best examples of leadership, innovation and impact in key areas that affect women’s health and wellbeing. #

The Research Project of the Year Award is sponsored by Future Fertility.

Future Fertility is the leader in AI-powered oocyte quality assessment, backed by the industry’s largest and most diverse oocyte dataset.

With an ability to seamlessly integrate into all laboratory set-ups, including time-lapse and microscope-only, Future Fertility’s clinically validated tools have been adopted in more than 25 countries.

Personalised insights gained via Future Fertility’s oocyte quality reports empower clinicians, embryologists, and patients with more precise information to guide future treatment planning and manage expectations for success.

A winner from the shortlist will be chosen by the sponsor and announced at a virtual ceremony on May 28.

Congratulations to the shortlisted organisations and thank you to everyone who entered.

Research Project of the Year Shortlist

In a research landscape that often prioritises men, research is crucial for addressing the significant gender health gap by providing factual information that can empower women to better understand their health.

Flo Health acknowledges the critical need for women’s health research and leverages its position as the leading women’s health app to conduct anonymised research using its extensive global database.

This submission highlights two significant studies conducted by Flo in 2024, published in the prestigious Nature Portfolio Journals: npj Women’s Health and Scientific Reports.

The phantom uterus project is a groundbreaking innovation in women’s healthcare, addressing the long-standing gender health gap by providing an anatomically and mechanically accurate model for medical device design and testing.

By integrating advanced medical imaging, computational modelling and materials science, this research enables safer, more effective and patient-centred gynaecological device development, minimising reliance on live patient trials.

With an 80 per cent performance score in a medical device validation study of a speculum, the phantom uterus demonstrates exceptional potential in refining medical devices before clinical use.

Mira is a San Francisco-based hormonal health company providing integrative care and hormonal testing for over 130,000 customers.

In support of Menopause Awareness Month, Mira conducted a survey to explore the impact of menopause on an individual’s life and career.

This survey was conducted as a cross-sectional survey of 1,000 American women over the age of 35.

Its purpose was to find out how perimenopause and menopause affect(ed) the life and career experience of the respondents.